Blood tests may unlock secrets of heart failure in metabolic syndrome
NCT ID NCT02446327
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at blood samples from 47 patients in France (part of a larger European study) to find biological markers linked to diastolic heart failure in people with metabolic syndrome. The goal was to confirm earlier findings about these markers. Participants had signs of heart failure but no recent heart attack or major health issues. The study did not test any treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify biological markers to better diagnose or predict diastolic heart failure in people with metabolic syndrome.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks for patterns in blood samples, so it won't directly improve health. Results may not lead to new tests or therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIASTOLIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a broccoli sprout compound protect aging hearts?
- 2.2 million patients: does heart failure raise surgery death risk?
- Heart tissue study seeks clues to postmenopausal heart failure
- Breathing therapy tested for heart failure – trial stopped early
- Blood test may guide heart failure treatment to cut hospital returns
- Heart device trial aims to boost function in patients with preserved pumping ability